Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Spinabifida – Prenatal Aspects Dr R B Beattie Consultant in Fetal Medicine UHS Cardiff Overview of Presentation •Spina Bifida •Maternal Serum AFP •Amniotic Fluid AFP and Ach •Anomaly Scan (18-22 weeks) •3D Scan and MRI •First Trimester Scan (11-13 weeks) •Fetal Surgery Anatomy of Spinabifida AC Malformation Myelomeningocoele Anatomy of Spinabifida Meningocoele Myelomeningocoele Anatomy of Spinabifida Myelomeningocoele Types of Spinabifida Ventriculomgaly / Hydrocephalus Risk factors for NTD Risk Factor Incidence General incidence 1.4–1.6 Amniocentesis for advanced maternal age 1.5–3.0 Diabetes mellitus 20 Valproic acid in first trimester 10–20 One sibling with NTD 15–30 Two siblings with NTD* 57 Parent with NTD 11 Half sibling with NTD 8 First cousin (mother's sister's child) 10 Other first cousins 3 Sibling with severe scoliosis secondary to multiple vertebral defects 15–30 Sibling with occult spinal dysraphism 15–30 Sibling with sacrococcygeal teratoma or hamartoma 15–30 NTD, neural tube defect. *Risk is higher in UK studies. Risk increases further for three or more siblings or combinations of other close relatives. Main DM, Mennuti MT: Neural tube defects: Issues in prenatal diagnosis and counseling. Obstet Gynecology 67:1–15, 1986. Causes of NTD Multifactorial inheritance Single-gene (autosomal recessive) disorders Meckel syndrome (most common) Robert syndrome Jarcho-Levin syndrome Median facial cleft syndrome HARDE (Walker-Warburg) syndrome Oculo-auriculo-vertebral (Goldenhar) syndrome Teratogens Valproic acid Carbamazepine Aminopterin Thalidomide Oral isotretinoin Chromosomal aneuploidy Trisomy 18 Trisomy 13 Trisomy 21 Triploidy Unbalanced translocations, markers, ring chromosomes Amniotic band sequence Cloacal extrophy Sacrococcygeal teratoma Maternal IDDM MSAFP and Spinabifida Fetal, Amniotic & Maternal AFP Fetal (mg) Amniotic Fluid (ug) Maternal (ng) •Fig. 4. Alpha-fetoprotein values in different compartments. A. Fetal serum. B. Amniotic fluid. C. Maternal serum. •Notice the various laboratory units for each graph. • (Habib A: Maternal serum alpha-fetoprotein: Its value in antenatal diagnosis of genetic disease and obstreticical-gynecologic care. •Acta Obstet Gynecol Scand 6(Suppl): 14, 1977.) MSFAP Screening Programme Fig. 5. Anticipated results for MSAFP screening of 10,000 prenatal patients. (Adapted from Haddow JE: Screening for spinal defects. Hosp Pract 17:128–138, 1982.) MSAFP Limitations False-Positive Levels Inaccurate gestational dating (patient > gestation than estimated) Multiple gestation Race (black patients have higher levels than white patients) Underweight patients (less than 90 pounds) Spontaneous fetal to maternal bleeding False-Negative Levels Inaccurate gestational dating (patient < gestation than estimated) Maternal insulin-dependent diabetes mellitus Obesity Amniotic Acetylchoinesterase • If AAFP is high then check AChe • AChE found in red blood cells, muscle, and neural tissue. • Concentrations of AChE are much higher in fetal cerebrospinal fluid than in fetal serum. • If the fetus has an open NTD, amniotic fluid AFP and AChE are usually both elevated and the high concentration of AChE in cerebrospinal fluid transudates across the defect into the amniotic fluid. • AChE is a sensitive test for confirming an open NTD. Fetal blood contamination is the most common source of falsely elevated AFP levels in amniotic fluid, and the amniocentesis performed to obtain the sample is the most common cause of fetal blood in the fluid. • In such cases, amniotic fluid AFP is usually in the 3–5 standard deviation range. AChE is not detected in 90% of cases because of the relatively low AChE concentrations in the fetal blood. • In congenital (Finnish) nephrosis, a rare autosomal recessive disorder, amniotic fluid AFP levels may be very high, and AChE is not identified. High MSAFP but no NTD •Ventral wall defects Omphalocele Gastroschisis •Triploidy •Trisomies: 18, 13, 21 •Unbalanced translocations •Amniotic band sequence •Pentalogy of Cantrell: omphalocele, lower sternal defect, deficiency of diaphragmatic pericardium, intracardiac abnormality, anterior diaphragm defect •Renal agenesis •Fetal demise •Multiple gestation •Congenital nephrosis (Finnish type) •Sacrococcygeal teratoma •Dermatologic disorders •Epidermolysis bullosa •Congenital icthyosiform erythroderma •Chorioangioma •Maternal hepatoma •Maternal ovarian teratoma Anomaly Scan – Normal Brain Anomaly Scan – Normal Spine 3D Scan – Normal Spine 2D Scan - Spinabifida Lemon Sign Banana Spinabifida Spinabifida Spinabifida 2D Scan - Myelomeningocoele •http://www.sonoworld.com/fetus/page.aspx?id=2504 3D Scan - Myelomeningocoele •http://www.sonoworld.com/fetus/page.aspx?id=2504 3D Scan & MRI - Myelomeningocoele A C 3D Scan shows accurate vertebral level of spina bifida (A) MRI shows chiari type II malformation and spinal cord inside the spinal canal (C) D B In late pregnancy MRI better than 3D scan as cerebrospinal region and intravertebral structure not seen well due to because of cranial/vertebral ossification (D) 2D Scan -11 to 13 weeks Normal NB P MB 1.5 to 2.5mm NT Mid-sagittal plane of the fetal face showing the nasal bone, palate, mandible, nuchal translucency (NT), thalamus (T), midbrain (MB), brain stem (B) and medulla oblongata (MO). Fourth ventricle 1.5 to 2.5mm 2D Scan -11 to 13 weeks Spinabifida NB P MB NT Mid-sagittal plane of the fetal face showing the nasal bone, palate, mandible, nuchal translucency (NT), thalamus (T), midbrain (MB), brain stem (B) and medulla oblongata (MO). Fourth ventricle is compressed. 2D Scan – Spinafida Mid-sagittal plane of the fetal face in a case of open spina bifida demonstrating compression of the fourth ventricle with no visible translucency. 2D Scan – Spinabifida video Mid-sagittal plane of the fetal faces in spina bifida. The arrows point to the brain stem with absence of the fourth ventricle 2D Scan – Spinabifida video Early BPD and Spinabifida Screening for fetal spina bifida by ultrasound examination in the first trimester of pregnancy using fetal biparietal diameter. OBJECTIVE: We assessed screening potential of simple and reproducible fetal biometry at 11-14 weeks STUDY DESIGN: 34,951 unselected consecutive pregnancies included 18 with spina bifida. Another 28 cases were referred for assessment. Biometric measurements were expressed in multiples of the median for crown-rump length. RESULTS: Biparietal diameter (BPD) <5th centile in spina bifida (P < .0001). In all, 22 of 44 (50%) cases with spina bifida aperta had a BPD <5th centile. CONCLUSION: BPD simple and reproducible 5% had BPD < 5th centile identifying 50% cases of open spina bifida Am J Obstet Gynecol. 2012 Oct;207(4):306.e1-5. doi: 10.1016/j.ajog.2012.05.014. Epub 2012 May 18. Fetal Surgery – MOMS Study • MOMS began 2003. • 200 women 18+ years • Enroll before 25 weeks • RCT – Postnatal versus fetal surgery • Fetal surgery 19-25 weeks •Fetal surgery group stay local until delivery • Delivery by CS around 37 weeks ?Reduced AC Malformation ?Reduced Shunting ?Improved ambulation Fetal Surgery - video